Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
J Neurosurg
; 124(1): 51-8, 2016 Jan.
Article
em En
| MEDLINE
| ID: mdl-26162034
Palavras-chave
ACA = anterior cerebral artery; BA = basilar artery; BP = blood pressure; CBF = cerebral blood flow; CCT = cranial computed tomography; CVS; CVS = cerebral vasospasm; DIND; DIND = delayed ischemic neurological deficit; DSA = digital subtraction angiography; GCS = Glasgow Coma Scale; HES = hydroxyethyl starch; HH = Hunt and Hess; ICA = internal carotid artery; ICP = intracranial pressure; MAP = mean arterial blood pressure; MCA = middle cerebral artery; MTG = molsidomine treatment group; NO; NO = nitric oxide; SAH = subarachnoid hemorrhage; STG = standard therapy group; TCD = transcranial Doppler; VA = vertebral artery; mNIHSS = modified National Institutes of Health Stroke Scale; mRS = modified Rankin Scale; molsidomine; subarachnoid hemorrhage; vascular disorders; vasospasm
Texto completo:
1
Base de dados:
MEDLINE
Métodos Terapêuticos e Terapias MTCI:
Terapias_biologicas
/
Aromoterapia
Assunto principal:
Hemorragia Subaracnóidea
/
Vasodilatadores
/
Molsidomina
/
Isquemia Encefálica
/
Infarto Encefálico
/
Vasoespasmo Intracraniano
/
Doenças do Sistema Nervoso
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
J Neurosurg
Ano de publicação:
2016
Tipo de documento:
Article